Buyback of Class B shares in Essity during week 11, 2025 Buyback program completed
Between March 10, 2025, and March 13, 2025, Essity Aktiebolag (publ) repurchased a total of 188,500 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The buyback program that was initiated on June 17, 2024, is hereby completed as a total of 10,070,500 Class B shares have been repurchased for a total amount of SEK 3bn.
The share repurchase has been financed using cash flow from current operations after the ordinary dividend. The ambition is to continue with share buybacks over time as a recurring part of Essity’s capital allocation.
The buyback program was implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).
Class B shares in Essity were repurchased as follows:
| Date | Aggregated daily volume (no. of shares): | Weighted average price per day (SEK): | Total daily transaction value (SEK): |
| March 10, 2025 | 54,000 | 308.5896 | 16,663,838 |
| March 11, 2025 | 54,000 | 308.8350 | 16,677,090 |
| March 12, 2025 | 54,000 | 303.9664 | 16,414,186 |
| March 13, 2025 | 26,500 | 299.1368 | 7,927,125 |
| Total accumulated during week 11 2025 | 188,500 | 306.0066 | 57,682,239 |
| Total accumulated during the buyback program | 10,070,500 | 297.8913 | 2,999,913,927 |
All purchases were conducted on Nasdaq Stockholm by Danske Bank on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on March 13, 2025, to 10,070,500 Class B shares. The total number of shares in Essity amounted on the date of this press release to 702,342,489, of which 58,973,654 Class A shares and 643,368,835 Class B shares.
For further information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
Tags: